Vol. 5 — September-October 2011

• Glomerular filtration rate in early diabetes: ongoing discussions of causes and mechanisms
  

  Sebastian Frische¹

  (1) The Water and Salt Research Center, University of Aarhus, Aarhus - Denmark and Institute of Anatomy, University of Aarhus, Aarhus - Denmark

• Aliskiren: the first direct renin inhibitor available for clinical use
  

  Alberto Morganti¹, Chiara Lonati¹

  (1) Department of Internal Medicine and Hypertension Center, San Giuseppe Hospital, University of Milan, Milan - Italy

• Do HMG-CoA reductase inhibitors improve kidney function? The saga continues
  

  Vito M. Campese¹, Elaine Ku¹, Roberto Bigazzi¹, Stefano Bianchi¹

  (1) Division of Nephrology, Keck School of Medicine, University of Southern California, Los Angeles, California - USA

• Acute kidney injury in pregnancy: the thrombotic microangiopathies
  

  Chitra Ganesan¹, Sharon E. Maynard¹

  (1) Department of Medicine, Division of Renal Diseases and Hypertension, George Washington University School of Medicine and Health Sciences, Washington, DC - USA

• Erythropoietin and the truths of science
  

  Michele Buemi¹, Susanna Campo¹, Valeria Cernaro¹, Valentina Donato¹, Antonio Lacquaniti¹

  (1) Division of Nephrology, Department of Internal Medicine, University of Messina, Messina - Italy

• Renal protection with angiotensin receptor blockers: where do we stand
  

  Roland E. Schmieder¹, Luis-Miguel Ruilope², Anthony H. Barnett³

  (1) Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen - Germany
  (2) Nephrology Service, Hypertension Unit, Hospital of 12 October, Madrid - Spain
  (3) Division of Clinical and Experimental Medicine, University of Birmingham and Diabetes Centre, Heart of England NHS Foundation Trust, Birmingham - UK

• OxPL/apoB, lipoprotein(a) and OxLDL biomarkers and cardiovascular disease in chronic hemodialysis patients
  

  Maurizio Bossola¹, Luigi Tazza¹, Giovanna Luciani¹, Antonio Tortorelli¹, Sotirios Tsimikas²

  (1) Hemodialysis Service, Catholic University, Rome - Italy
  (2) Division of Cardiovascular Diseases, University of California, San Diego, California – USA

• Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease
  

  Björn Wikström¹, Sunil Bhandari², Peter Barany³, Philip A. Kalra⁴, Søren Ladefoged⁵, Jan Wilske⁶, Lars L. Thomsen⁷

  (1) Department of Renal Medicine, Uppsala University, Uppsala - Sweden
  (2) Department of Renal Medicine, Hull and East Yorkshire Hospitals NHS Trust, and Hull York Medical School, East Yorkshire - UK
  (3) Department of Renal Medicine, CLINTEC, Karolinska Institutet, Stockholm - Sweden
  (4) Department of Renal Medicine, Salford Royal Hospital, Salford - UK
  (5) Department of Nephrology, University Hospital of Copenhagen, Copenhagen - Denmark
  (6) Department of Renal medicine, Värnamo Hospital, Värnamo - Sweden
  (7) Pharmacosmos A/S, Holbaek - Denmark

• Distribution and complications of native arteriovenous fistulas in maintenance hemodialysis patients: a single-center st
  

  Qing Yu¹, Hua Yu², Sheng Chen¹, Lijun Wang¹, Weijie Yuan¹

  (1) Division of Nephrology, Shanghai First People’s Hospital Affiliated to Jiaotong University, Shanghai - PR China
  (2) The Affiliated Cardiovascular Hospital of Medical College, Qingdao University, Qingdao, Shandong Province - PR China

• What causes an improved safety climate among the staff of a dialysis unit? Report of an evaluation in a large network
  

  Attilio Di Benedetto¹, Francesco Pelliccia¹, Manuela Moretti¹, Wanda d’Orsi¹, Fernando Starace², Laura Scatizzi³, Maria Teresa Parisotto³, Daniele Marcelli³

  (1) Fresenius Medical Care, NephroCare Italy, Napoli - Italy
  (2) Fresenius Medical Care, NephroCare Italy, Napoli – Italy
  (3) Fresenius Medical Care, NephroCare Coordination, Bad Homburg - Germany

• Good outcomes with Cyclosporine very low exposure with Everolimus high exposure in renal transplant patients
  

  Elisabetta Bertoni¹, Aida Larti¹, Giuseppina Rosso¹, Maria Zanazzi¹, Lorenzo Di Maria¹, Maurizio Salvadori¹

  (1) Renal Unit, Careggi University Hospital, Florence - Italy

• Validation of a prognostic function for renal transplant recipients in Hungary
  

  Réka P. Szabó^1,2, László Asztalos^3,2, László Szabó^3,2, József Balla^1,2, Zoltán Vokó^4,2

  (1) First Department of Internal Medicine, Division of Nephrology, Faculty of Medicine, Medical &
  (2) Health Science Centre, University of Debrecen, Debrecen - Hungary
  (3) Institute of Surgery, Center of Transplantation, Faculty of Medicine, Medical &
  (4) Department of Preventive Medicine, Faculty of Public Health, Medical &

• No influence of haemodialysis on interferon production in the QuantiFERON-TB Gold-In-Tube test
  

  Martine Hoogewerf^1,2, Greet J. Boland³, Andy I.M. Hoepelman^1,2, Walther H. Boer^4,5, Tania Mudrikova^1,2

  (1) Department of Internal Medicine &
  (2) Infectious Diseases, University Medical Center Utrecht, Utrecht - The Netherlands
  (3) Department of Medical Microbiology and Virology, University Medical Center Utrecht, Utrecht - The Netherlands
  (4) Department of Nephrology &
  (5) Hypertension, University Medical Center Utrecht, Utrecht - The Netherlands

• Homocysteine-dependent endothelial dysfunction induced by renal ischemia/reperfusion injury
  

  Yagnik S. Bhalodia¹, Navin R. Sheth², Jitendra D. Vaghasiya³, Nurudin P. Jivani⁴

  (1) Department of Pharmaceutical Sciences, Jodhpur National University, Narnadi, Jodhpur, Rajasthan - India
  (2) Department of Pharmaceutical Sciences, Saurashtra University, Rajkot, Gujarat - India
  (3) Smt. R. B. Patel Mahila Pharmacy College, Gujarat Technological University, Kailashnagar, Atkot, Gujarat - India
  (4) Smt. R. B. Patel Mahila Pharmacy College, Gujarat Technological University, Kailashnagar, Atkot, Gujarat – India

• Aspirin resistance in patients with chronic renal failure
  

  Azra Meryem Tanrikulu¹, Beste Ozben¹, Mehmet Koc², Nurdan Papila-Topal¹, Tomris Ozben³, Oguz Caymaz¹

  (1) Department of Cardiology, Marmara University Faculty of Medicine, Istanbul - Turkey
  (2) Division of Nephrology, Department of Internal Medicine, Marmara University Faculty of Medicine, Istanbul - Turkey
  (3) Department of Biochemistry, Akdeniz University Faculty of Medicine, Antalya - Turkey

• The role of bone morphogenetic protein-5 (BMP-5) in human nephrosclerosis
  

  Carsten P. Bramlage¹, Gerhard A. Müller¹, Björn Tampe¹, Jelena Bevanda¹, Imad Maatouk¹, Michael Koziolek¹, Katharina Lange², Katharina Ahrens³, Holger Schmid⁴, Clemens D. Cohen⁵, Peter Bramlage³, Matthias Kretzler⁶, Frank Strutz¹

  (1) Department of Medicine, Nephrology and Rheumatology, Georg-August-University Göttingen, Göttingen - Germany
  (2) Department of Medical Statistics, Georg-August-University Göttingen, Göttingen - Germany
  (3) Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow - Germany
  (4) Department of Nephrology, Medical Policlinic, Ludwig Maximilians University Munich, Munich - Germany
  (5) Division of Nephrology and Institute of Physiology, University Zürich, Zürich - Switzerland
  (6) Internal Medicine, Nephrology, University of Michigan, Ann Arbor, Michigan - USA

• Accumulation of renin and imidazolone in peritubular capillary endothelial cells in insulin-resistant hypertensive rats
  

  Zoltán Wagner¹, Péter Degrell¹, Balázs Lukáts², Toshimitsu Niwa³, Gergo A. Molnár¹, Lajos Markó¹, Zoltán Karádi⁴, István Wittmann¹

  (1) Second Department of Medicine and Nephrological Center, University of Pécs, Pécs - Hungary
  (2) Institute of Physiology and Neurophysiology Research Group of the Hungarian Academy of Sciences, Faculty of Medicine, University of Pécs, Pécs - Hungary
  (3) Department of Clinical Preventive Medicine, Nagoya University Hospital, Nagoya - Japan
  (4) Institute of Physiology and Neurophysiology Research Group of the Hungarian Academy of Sciences, Faculty of Medicine, University of Pécs, Pécs – Hungary

• Looking at appearance of urine before performing a renal biopsy in nephrotic syndrome
  

  Giorgio Graziani¹, David Cucchiari¹, Simona Verdesca¹, Luca Balzarini², Alessandro Montanelli³, Claudio Ponticelli¹

  (1) Nephrology and Dialysis Unit, Humanitas Clinical Institute, Rozzano, Milan?- Italy
  (2) Magnetic Resonance Section, Department of Radiology, Humanitas Clinical Institute, Rozzano, Milan - Italy
  (3) Biochemical and Clinical Laboratory, Humanitas Clinical Institute, Rozzano, Milan - Italy